| Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia (NCT06111027) | University of Minnesota | 2023-11-21 |
| A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO (NCT06176963) | Samsung Bioepis Co., Ltd. | 2023-11-21 |
| Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery (NCT06457100) | The Second People's Hospital of Huai'an | 2023-11-21 |
| Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease (NCT06189963) | NKGen Biotech, Inc. | 2023-11-21 |
| Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases (NCT06078813) | Cancer Trials Ireland | 2023-11-21 |
| Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations (NCT06029816) | Convalife (Shanghai) Co., Ltd. | 2023-11-20 |
| RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection (NCT06149494) | Altesa Biosciences, Inc. | 2023-11-20 |
| Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations (NCT06027229) | University of Wisconsin, Madison | 2023-11-20 |
| A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) (NCT06035497) | Bristol-Myers Squibb | 2023-11-20 |
| Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients (NCT05844527) | MedRegen LLC | 2023-11-20 |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer (NCT06129851) | University of Kansas Medical Center | 2023-11-20 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients (NCT06548854) | Grand Medical Pty Ltd. | 2023-11-20 |
| Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer (NCT04515004) | VA Office of Research and Development | 2023-11-20 |
| Gabapentin to Reduce Alcohol and Improve Viral Load Suppression (NCT05443555) | Boston Medical Center | 2023-11-20 |
| Impact of SGLT2 Inhibitors in Heart Transplant Recipients (NCT06147271) | Universidade Federal do Ceara | 2023-11-20 |
| Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1) (NCT06300476) | West China Hospital | 2023-11-20 |
| Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (NCT06078709) | Mayo Clinic | 2023-11-20 |
| Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER) (NCT06557525) | UNB Sumiyoshi Jinja Mae Clinic | 2023-11-20 |
| A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) (NCT06100874) | Adrienne G. Waks | 2023-11-20 |
| A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model (NCT06170242) | Enanta Pharmaceuticals, Inc | 2023-11-20 |
| Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis (NCT06166576) | Seoul National University Hospital | 2023-11-20 |
| Effectiveness of Asiaticoside as Intracanal Medication on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis (NCT06566508) | Mansoura University | 2023-11-20 |
| A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease. (NCT06185543) | NeuroSense Therapeutics Ltd. | 2023-11-19 |
| Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer (NCT05839470) | Fujian Cancer Hospital | 2023-11-19 |
| Ivermectin Safety in Small Children (NCT04332068) | University of Oxford | 2023-11-18 |
| A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage (NCT05970224) | Bioxodes S.A. | 2023-11-17 |
| Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases (NCT05789589) | Baptist Health South Florida | 2023-11-17 |
| A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension (NCT06137742) | Pfizer | 2023-11-17 |
| A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma (NCT05808608) | Hao Zeng | 2023-11-17 |
| A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight (NCT06124807) | Eli Lilly and Company | 2023-11-17 |
| [68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer (NCT05903807) | Aalborg University Hospital | 2023-11-17 |
| A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight (NCT06143956) | Eli Lilly and Company | 2023-11-17 |
| PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health (NCT06186531) | NeuTherapeutics | 2023-11-17 |
| A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma (NCT06104553) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-11-17 |
| A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease (NCT06055985) | UCB Biopharma SRL | 2023-11-17 |
| Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (NCT06101329) | Gilead Sciences | 2023-11-17 |
| Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor (NCT06057571) | TransThera Sciences (Nanjing), Inc. | 2023-11-17 |
| Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC) (NCT05856695) | Intergroupe Francophone de Cancerologie Thoracique | 2023-11-17 |
| Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes (NCT06104358) | Rivus Pharmaceuticals, Inc. | 2023-11-17 |
| Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance (NCT05796375) | White River Junction Veterans Affairs Medical Center | 2023-11-17 |
| Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer (NCT06341894) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-17 |
| Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors (NCT06243185) | Fengzhi Feng | 2023-11-17 |
| Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation (NCT05491226) | Stephen Shiao | 2023-11-17 |
| A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA） (NCT05979051) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-11-16 |
| Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer (NCT05983276) | Loyola University | 2023-11-16 |
| A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer (NCT06145412) | Memorial Sloan Kettering Cancer Center | 2023-11-16 |
| Total Neoadjuvant Therapy in Rectal Cancer (NCT06162650) | National Cheng-Kung University Hospital | 2023-11-16 |
| Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma (NCT06133062) | Chang Gung Memorial Hospital | 2023-11-16 |
| A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants (NCT05963984) | Carrick Therapeutics Limited | 2023-11-16 |
| A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT05999799) | GlaxoSmithKline | 2023-11-16 |
| Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma (NCT06091124) | RenJi Hospital | 2023-11-16 |
| Dose Finding Study for Remimazolam in Children (NCT05975255) | Seoul National University Hospital | 2023-11-16 |
| Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis (NCT06097260) | Pliant Therapeutics, Inc. | 2023-11-16 |
| ZN-c3 + Gemcitabine in Pancreatic Cancer (NCT06015659) | Brandon Huffman, MD | 2023-11-16 |
| Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA (NCT06020014) | AstraZeneca | 2023-11-16 |
| A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors (NCT06008054) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-11-16 |
| Pembro Plus CAR T-cell Therapy in R/R in PMBCL (NCT05934448) | Jennifer Crombie, MD | 2023-11-15 |
| Chiglitazar/Metformin in Non-obese Women With PCOS (NCT06125587) | Shengjing Hospital | 2023-11-15 |
| Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer (NCT06103617) | Nanfang Hospital, Southern Medical University | 2023-11-15 |
| Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD) (NCT05643729) | ZEO ScientifiX, Inc. | 2023-11-15 |
| Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT05724602) | European Organisation for Research and Treatment of Cancer - EORTC | 2023-11-15 |
| Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings (NCT06667206) | University of Oxford | 2023-11-15 |
| Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma (NCT05970666) | The First Affiliated Hospital of Xiamen University | 2023-11-15 |
| A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT06136351) | Ruijin Hospital | 2023-11-15 |
| Gene Therapy for DME (NCT06492876) | Frontera Therapeutics | 2023-11-15 |
| A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (NCT06136741) | Nektar Therapeutics | 2023-11-15 |
| Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine (NCT06181292) | Hipra Scientific, S.L.U | 2023-11-15 |
| Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT06051357) | Chengdu Suncadia Medicine Co., Ltd. | 2023-11-15 |
| A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers (NCT06143046) | ModernaTX, Inc. | 2023-11-15 |
| Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer (NCT06134271) | Jianbin Bi | 2023-11-15 |
| A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients (NCT06292923) | Tiziana Life Sciences LTD | 2023-11-15 |
| IMM60 and Pembrolizumab in Melanoma and NSCLC (NCT05709821) | iOx Therapeutics | 2023-11-15 |
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (NCT05794659) | Aston Sci. Inc. | 2023-11-15 |
| Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension (NCT06152861) | Glaukos Corporation | 2023-11-15 |
| Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma (NCT06142318) | Nanfang Hospital, Southern Medical University | 2023-11-15 |
| Ultrasound Guided Pericapsular Nerve Block Versus iv Sedation Analgesia in Reduction of Shoulder Dislocation (NCT06034873) | Benha University | 2023-11-15 |
| Study of LAU-7b for the Treatment of Long COVID in Adults (NCT05999435) | Laurent Pharmaceuticals Inc. | 2023-11-15 |
| Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer (NCT06359847) | Beijing Scitech-Mq Pharmaceuticals Limited | 2023-11-15 |
| Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A (NCT05720065) | Karolinska Institutet | 2023-11-14 |
| A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 (NCT06062420) | GlaxoSmithKline | 2023-11-14 |
| A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT05923008) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-11-14 |
| A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma (NCT05583617) | Hoffmann-La Roche | 2023-11-14 |
| A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) (NCT06275620) | Beacon Therapeutics | 2023-11-14 |
| Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults (NCT05835479) | Mundipharma Research Limited | 2023-11-14 |
| A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 (NCT06003231) | Seagen, a wholly owned subsidiary of Pfizer | 2023-11-14 |
| Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors (NCT06128551) | Revolution Medicines, Inc. | 2023-11-14 |
| Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars (NCT06138964) | National Skin Centre | 2023-11-14 |
| Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study (NCT03710343) | Holland Bloorview Kids Rehabilitation Hospital | 2023-11-14 |
| Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT07511972) | NGM Biopharmaceuticals, Inc | 2023-11-14 |
| FIH XON7 in Advanced/Metastatic Solid Tumors (NCT06154291) | Xenothera SAS | 2023-11-14 |
| ACP-204 in Adults With Alzheimer's Disease Psychosis (NCT06159673) | ACADIA Pharmaceuticals Inc. | 2023-11-14 |
| HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies (NCT05658640) | Princess Maxima Center for Pediatric Oncology | 2023-11-14 |
| Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes (NCT05918055) | National Cancer Institute (NCI) | 2023-11-14 |
| Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies (NCT05979610) | University of Utah | 2023-11-14 |
| A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma (NCT06016452) | Tata Memorial Centre | 2023-11-13 |
| Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (NCT05784012) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2023-11-13 |
| Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer (NCT06124378) | First Affiliated Hospital of Guangxi Medical University | 2023-11-13 |
| Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma (NCT06246162) | Affiliated Hospital of Nantong University | 2023-11-13 |
| Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (NCT05960955) | Akeso | 2023-11-13 |
| A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria (NCT06069544) | BioNTech SE | 2023-11-13 |